Live Updates Live Coverage Has Ended Palantir May Have Another 18% of Upside 1:12 pm Using the high-end of analyst price ...

Trump said he's poised to unveil a "major" trade deal, boosting optimism that the tide has turned in the tariff hostilities.

Palantir's Q1 earnings failed to meet guidance expectations, driving selloff concerns. Find out if PLTR has more to rise or ...

Palantir's artificial intelligence platform (AIP) continues to be its primary growth driver, particularly with U.S. commercial customers. The company credited AIP's ontology, or the operational layer ...

Palantir reported a 71% increase in U.S. commercial revenue and a 45% gain in U.S. government revenue in the period, showing ...

The rise of artificial intelligence (AI) is expected to add $15.7 trillion to the worldwide economy by 2030. AI colossus ...

Palantir Technologies ( PLTR 1.44%) shares have advanced 550% since January 2024. For context, it was the best performing ...

Despite impressive revenue and operating income growth, Palantir shares dropped 12%. Read what warrants caution about PLTR ...

Palantir's recent earnings show it's not just surviving the AI arms race—it’s winning key battles. Despite global AI ...

Smaller-scale trades involved Pacific Biosciences of California Inc (NASDAQ: PACB) and 10X Genomics Inc (NASDAQ: TXG ), with ARK purchasing 194,298 and 18,177 shares respectively, totaling $213,727 ...

Shares have advanced in Asia after the U.S. and China said they are planning trade talks in Switzerland later this week ...

Palantir Technologies shares are down 11.4% this week. The stock is down despite Palantir delivering solid first-quarter ...